Citius Pharmaceuticals In...

NASDAQ: CTXR · Real-Time Price · USD
1.33
0.02 (1.53%)
At close: Aug 15, 2025, 3:59 PM
1.35
1.49%
After-hours: Aug 15, 2025, 06:24 PM EDT

Citius Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-39.43M -32.54M -33.64M -23.05M
Depreciation & Amortization
209.61K 194.32K 179.68K 164.87K
Stock-Based Compensation
11.84M 6.62M 3.91M 1.45M
Other Working Capital
-1.55M -5.77M 351.27K -2.14M
Other Non-Cash Items
284.18K 102K 378.2K 68K
Deferred Income Tax
576K 576K 576K -166.56K
Change in Working Capital
-1.69M -4.01M 239.56K -2.72M
Operating Cash Flow
-28.2M -29.06M -28.36M -24.25M
Capital Expenditures
n/a 2.00 n/a -40.01M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-5M n/a n/a -40K
Investing Cash Flow
-5M n/a n/a -40.01M
Debt Repayment
n/a n/a n/a -172.97K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-3.83M 31.27K n/a 31.21M
Financial Cash Flow
9.97M 13.83M n/a 120.47M
Net Cash Flow
-23.23M -15.23M -28.36M 56.21M
Free Cash Flow
-28.2M -29.06M -28.36M -64.26M